Any dip is a buying opportunity target 100 and above

Moderna is showing strong signs of institutional accumulation — large funds like Morgan Stanley, Geode, and State Street have significantly increased their positions this year.🎯 Short-term target: $100+

Institution Shares Added (Approx) Timing
Catalyst Funds Mgmt 35,200 Q4 2024
Wealthquest Corp 36,587 Q1 2025
LVW Advisors LLC 10,500 Q1 2025
Ieq Capital LLC 7,194 Q4 2024
Proficio Capital Partners 144,099 Q4 2024
Geode Capital Management 171,774 Q4 2024
Tokio Marine AM 1,715 Q4 2024
Empowered Funds LLC 582 Q4 2024
Morgan Stanley +3.19 M → 7.44 M Q1 2025
State Street, Invesco, Two Sigma, D.E. Shaw added hundreds of thousands Q1 2025

🧠 Interpretation
Broad-based accumulation: from smaller hedge funds to large wealth managers.

Major boost from Morgan Stanley, State Street, Geode, Two Sigma, etc., in Q1.

75% institutional ownership highlights deep conviction and alignment with long-term fundamentals.

There has been significant institutional buying of Moderna this year, notably by Morgan Stanley and other large asset managers, plus smaller institutional inflows from Catalyst, Wealthquest, Ieq, LVW, and more. This suggests growing confidence among sophisticated investors in MRNA’s outlook.